1. Gray DS. Diagnosis and prevalence of obesity. Med Clin North Am 1989;73(1):1-13.
2. Jensen MD. Health consequences of fat distribution. Horm Res 1997;48(suppl 5):88-92.
3. Ministry of Health & Welfare, Korea Centers for Disease Control & Prevention. Health behavior and chronic disease statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3) Cheongju (Korea): Korea Centers for Disease Control & Prevention; 2015.
4. World Health Organization. Obesity and overweight Geneva (Switzerland): World Health Organization; 2003.
5. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8(9):605-19.
6. Abdullah A, Peeters A, Courten M, et al. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 2010;89(3):309-19.
7. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009;106(40):641-8.
8. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88.
9. Tsigos C, Hainer V, Basdevant A, et al. Obesity Management Task Force of the European Association for the Study of Obesity. Management of obesity in adults: European clinical practice guidelines. Obes Facts 2008;1(2):106-16.
10. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282(16):1523-9.
11. World Health Organization [Internet]. Global database on body mass index. OECD Health Statistics. WHO infobase. 2014 [cited 2017 May 30]. Available from:
http://apps.who.int/bmi/index.jsp.
12. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne (Australia): Health communications; 2000
14. Korea Centers for Disease Control and Prevention. Korea health statistics 2013: Korea National Health and Nutrition Examination Survey Seoul (Korea): Korea Ministry of Health and Welfare; 2015.
15. Korea Centers for Disease Control and Prevention. Korea health statistics 2014 Korea National Health and Nutrition Examination Survey (KNHANES VI-1) Seoul (Korea): Korea Ministry of Health and Welfare; 2014.
16. Allison DB, Zannolli R, Narayan KMV. The direct health care costs of obesity in the United States. Am J Public Health 1999;89(8):1194-9.
17. Birmingham CL, Muller JL, Palepu A, et al. The cost of obesity in Canada. CMAJ 1999;160(4):483-8.
18. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6(2):97-106.
19. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999;31(11 suppl):S663-7.
20. Kang JH, Jeong BG, Cho YG, et al. Medical expenditure attributable to overweight and obesity in adults with ischemic heart disease and stroke in Korea. Korean J Health Educ Promot 2010;27(4):83-90.
21. Saydah S, Bullard KM, Cheng Y, et al. Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999–2010. Obesity (Silver Spring) 2014;22(8):1888-95.
22. Bonow RO, Smaha LA, Smith SC Jr, et al. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106(13):1602-5.
23. Wang G, Zheng ZJ, Heath G, et al. Economic burden of cardiovascular disease associated with excess body weight in U.S. adults. Am J Prev Med 2002;23(1):1-6.
24. Higgins M, Kannel W, Garrison R, et al. Hazards of obesity: the Framingham experience. Acta Med Scand Suppl 1988;723:23-36.
25. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333(11):677-85.
26. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322(13):882-9.
27. Witteman JC, Willett WC, Stampfer MJ, et al. A prospective study of nutritional factors and hypertension among US women. Circulation 1989;80(5):1320-7.
28. Gillum RF, Taylor HL, Brozek J, et al. Indices of obesity and blood pressure in young men followed 32 years. J Chronic Dis 1982;35(3):211-9.
29. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women: risk within the “normal” weight range. JAMA 1995;273(6):461-5.
30. Trials of Hypertension Prevention Collaborative Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 1992;267(9):1213-20.
31. Davis BR, Blauxfox MD, Oberman A, et al. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with hypertension. Arch Intern Med 1993;153(15):1773-82.
32. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992;56(2):320-8.
33. Wood PD, Stefanick ML, Williams PT, et al. The effects on plasma lipoproteins of a prudent weight-reducing diet with or without exercise, in overweight men and women. N Engl J Med 1991;325(7):461-6.
34. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282(16):1523-9.
36. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther 2011;90(1):164-8.
37. Williamson DF, Madans J, Anda RF, et al. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991;324(11):739-45.
38. Carreras-Torres R, Johansson M, Haycock PC, et al. Role of obesity in smoking behaviour: Mendelian randomization study in UK Biobank. BMJ 2018;361:k1767.
39. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011;123(21):2434-506.
40. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34(28):2159-219.
41. Korean Academy of Medical Sciences. 2014 Evidence-based recommendations for hypertension in primary care Seoul (Korea): 2014.
42. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000;8(9):605-19.
43. Wilson PW, D’Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162(16):1867-72.
44. Abdullah A, Peeters A, de Courten M, et al. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 2010;89(3):309-19.
45. Korea Centers for Disease Control and Prevention. Factbook of non-communicable disease Cheongju (Korea): Korea Centers for Disease Control & Prevention; 2015.
46. Statistics Korea [Internet]. Causes of death statistics 2014. Daejeon (Korea): Statistics Korea; 2014 [cited 2017 Jul 10]. Available from:
http://kosis.kr/ups/ups_01List.jsp.
47. Yun SJ, Kim EJ, Kim HJ, et al. A study on measuring the economic burden of cardio-cerebrovascular disease in Korea Cheongju (Korea): Korea Centers for Disease Control & Prevention; 2010.
48. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75(3):473-86.
49. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364(9438):937-52.
50. Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298(22):2654-64.